These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10743496)

  • 1. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019).
    Gill HS; Rutherfurd KJ; Prasad J; Gopal PK
    Br J Nutr; 2000 Feb; 83(2):167-76. PubMed ID: 10743496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice.
    Zhou JS; Shu Q; Rutherfurd KJ; Prasad J; Birtles MJ; Gopal PK; Gill HS
    Int J Food Microbiol; 2000 May; 56(1):87-96. PubMed ID: 10857928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis.
    Zhou JS; Gill HS
    Int J Food Microbiol; 2005 Aug; 103(1):97-104. PubMed ID: 16084270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria.
    Zhou JS; Shu Q; Rutherfurd KJ; Prasad J; Gopal PK; Gill HS
    Food Chem Toxicol; 2000; 38(2-3):153-61. PubMed ID: 10717355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro.
    Zhou JS; Gopal PK; Gill HS
    Int J Food Microbiol; 2001 Jan; 63(1-2):81-90. PubMed ID: 11205957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli.
    Gopal PK; Prasad J; Smart J; Gill HS
    Int J Food Microbiol; 2001 Aug; 67(3):207-16. PubMed ID: 11518430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
    Zhou JS; Pillidge CJ; Gopal PK; Gill HS
    Int J Food Microbiol; 2005 Feb; 98(2):211-7. PubMed ID: 15681048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019.
    Gill HS; Rutherfurd KJ; Cross ML; Gopal PK
    Am J Clin Nutr; 2001 Dec; 74(6):833-9. PubMed ID: 11722966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection.
    Prescott SL; Wickens K; Westcott L; Jung W; Currie H; Black PN; Stanley TV; Mitchell EA; Fitzharris P; Siebers R; Wu L; Crane J;
    Clin Exp Allergy; 2008 Oct; 38(10):1606-14. PubMed ID: 18631345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice.
    Shu Q; Gill HS
    FEMS Immunol Med Microbiol; 2002 Sep; 34(1):59-64. PubMed ID: 12208607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice.
    Gill HS; Rutherfurd KJ
    Br J Nutr; 2001 Aug; 86(2):285-9. PubMed ID: 11502243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019).
    Arunachalam K; Gill HS; Chandra RK
    Eur J Clin Nutr; 2000 Mar; 54(3):263-7. PubMed ID: 10713750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001.
    Gill HS; Shu Q; Lin H; Rutherfurd KJ; Cross ML
    Med Microbiol Immunol; 2001 Dec; 190(3):97-104. PubMed ID: 11827205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro fermentation of prebiotic oligosaccharides by Bifidobacterium lactis HN019 and Lactobacillus spp.
    Sims IM; Ryan JL; Kim SH
    Anaerobe; 2014 Feb; 25():11-7. PubMed ID: 24239979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inability of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 to induce human platelet aggregation in vitro.
    Zhou JS; Rutherfurd KJ; Gill HS
    J Food Prot; 2005 Nov; 68(11):2459-64. PubMed ID: 16300090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of probiotic strains Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 on systemic immune functions and bacterial translocation in mice.
    Paturi G; Phillips M; Kailasapathy K
    J Food Prot; 2008 Apr; 71(4):796-801. PubMed ID: 18468035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses.
    Chiang BL; Sheih YH; Wang LH; Liao CK; Gill HS
    Eur J Clin Nutr; 2000 Nov; 54(11):849-55. PubMed ID: 11114680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
    Klein A; Friedrich U; Vogelsang H; Jahreis G
    Eur J Clin Nutr; 2008 May; 62(5):584-93. PubMed ID: 17440520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model.
    Kim JY; Choi YO; Ji GE
    J Microbiol Biotechnol; 2008 Aug; 18(8):1393-400. PubMed ID: 18756099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice.
    Shu Q; Lin H; Rutherfurd KJ; Fenwick SG; Prasad J; Gopal PK; Gill HS
    Microbiol Immunol; 2000; 44(4):213-22. PubMed ID: 10832963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.